June 16, 2020 / 11:16 PM / 16 days ago

BRIEF-Novartis Cosentyx Receives FDA Approval For New Indication To Treat Active Non-Radiographic Axial Spondyloarthritis

June 16 (Reuters) - Novartis AG:

* NOVARTIS COSENTYX® RECEIVES FDA APPROVAL FOR NEW INDICATION TO TREAT ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

* APPROVAL OF COSENTYX FOR NR-AXSPA IS BASED ON EFFICACY AND SAFETY OUTCOMES FROM PREVENT PHASE III STUDY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below